Clobazam clinical trials
Also written Onfi.
How each study uses Clobazam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 21 Oct 2011 · ONFI · NDA 202067 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2015 (4)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 9
Lundbeck LLC (3) · Jazz Pharmaceuticals (2) · Insel Gruppe AG, University Hospital Bern (2) · H. Lundbeck A/S (2) · King's College London (1) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1) · University Hospital, Geneva (1) · The Cooper Health System (1)
Often tested with
Tested in the same studies.
Clonazepam (3) · Cannabidiol (2) · Imipramine (2) · Lorazepam (2) · Oxycodone (1) · Tolterodine (1) · Phenobarbital (1) · Phenytoin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Anxiolytics source
- One of Benzodiazepines source
Studies
Open first, then newest update. How each study uses Clobazam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 16
- GABA Pathways in Autism Spectrum Disorder (ASD)CompletedNot applicableKing's College LondonNCT03678129Written as ClobazamHow we know
- A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedPhase 2Jazz PharmaceuticalsNCT02565108Written as ClobazamHow we know
- An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedPhase 2Jazz PharmaceuticalsNCT02564952Written as ClobazamHow we know
- Use of Clobazam for Epilepsy and AnxietyCompletedPhase 4Hugo W. Moser Research Institute at Kennedy Krieger, Inc.NCT03371836Written as ClobazamHow we know
- Clobazam Use in Epilepsia Partialis Continua - Pilot StudyTerminatedPhase 3The Cooper Health SystemNCT02134366Written as ClobazamHow we know
- Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut SyndromeCompletedPhase 3Lundbeck LLCNCT01160770Written as ClobazamHow we know
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as ClobazamHow we know
- Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet SyndromeTerminatedPhase 3H. Lundbeck A/SNCT02187809Written as ClobazamHow we know
- Clobazam Adjunctive Treatment of Adults With Refractory Focal EpilepsyStatus unknownPhase 4Pavel KleinNCT02726919Written as ClobazamHow we know
- Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory EpilepsyStatus unknownPhase 4St. Joseph's Hospital and Medical Center, PhoenixNCT01932502Written as clobazam (Onfi)How we know
- Linking Altered Central Pain Processing and Genetic Polymorphism to Drug Efficacy in Chronic Low Back Pain (Predictio)CompletedPhase 3Insel Gruppe AG, University Hospital BernNCT01179828Written as ClobazamHow we know
- Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet SyndromeWithdrawnPhase 3H. Lundbeck A/SNCT02174094Written as ClobazamHow we know
- Clobazam in Subjects With Lennox-Gastaut SyndromeCompletedPhase 2Lundbeck LLCNCT00162981Written as Clobazam Low DoseHow we know
- Clobazam in Patients With Lennox-Gastaut SyndromeCompletedPhase 3Lundbeck LLCNCT00518713Written as Clobazam Low DoseHow we know
- GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central SensitisationCompletedPhase 1/2University Hospital, GenevaNCT01291316Written as clobazamHow we know
- Effects of GABA-a-Agonists on Pain Mechanisms: An Experimental Study in Healthy VolunteersCompletedPhase 3Insel Gruppe AG, University Hospital BernNCT01011036Written as clobazamHow we know
As the comparator · 1 — what is tested is compared with Clobazam
Codes
What other systems call Clobazam · ClinicalTrials.gg INT006826
- MeSH (NLM) D000078306ClobazamConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2MRO291B4UCLOBAZAMConfirmed FDA, NLM, Wikidata
- RxNorm 21241Confirmed FDA, Wikidata
- Wikidata Q412164clobazamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81615ClobazamOne source FDA
- DrugBank DB00349One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078306 | Clobazam | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2MRO291B4U | CLOBAZAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 21241 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412164 | clobazam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81615 | Clobazam | One source FDA |
| DrugBank | DB00349 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.